Get the live share price of AstraZeneca PLC (AZN), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.
The average one-year price target for AstraZeneca PLC - Depositary Receipt (NasdaqGS:AZN) has been revised to $202.76 / share ...
Astrazeneca (AZN) ended the recent trading session at $76.28, demonstrating a -1.03% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.49 ...
Zacks Investment Research on MSN
Here's what key metrics tell us about AstraZeneca (AZN) Q4 earnings
Astrazeneca (AZN) reported $15.5 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 4.1%. EPS of $1.06 for the same period compares to $2.10 a year ago.
AstraZeneca PLC (NASDAQ:AZN) ranks among the best-performing European stocks to invest in. Following the release of Phase 3 trial data for baxdrostat at ESC 2025, Goldman Sachs reaffirmed its ...
Investors in AstraZeneca plc (Symbol: AZN) saw new options become available this week, for the February 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AZN ...
AstraZeneca PLC is a leading global pharmaceutical company with strong growth in oncology, diversified revenues, and a robust pipeline. AZN's financials show improving margins, rising EPS, and ...
AstraZeneca AZN reported fourth-quarter 2025 core earnings of $2.12 per share, which missed the Zacks Consensus Estimate of $2.18 per share. Earnings rose 1% year over year on a reported basis but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results